Cairo University
Cairo, Egypt
NCT Number: NCT03251170
The aim of this work is to compare two protocols (ketamine-midazolam versus fentanyl-midazolam) for induction of anesthesia in patients with septic shock aiming to find the most safe protocol with regards to hemodynamic status of patients
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
Cairo, Egypt
Induction of anesthesia in hemodynamically compromised patients is a challenge for every anesthetist. Most of the intravenous induction agents have a negative effect on arterial blood pressure and cardiac output. Theoretically, the "ideal" emergency induction intravenous anesthetic should achieve rapid hypnosis and maintain the hemodynamic stability.
Ketamine has been reported as an induction anesthetic with a sympathomimetic activity. In patients with intact autonomic nervous system ketamine increases heart rate, cardiac output, and arterial blood pressure (ABP). Despite its sympathomimetic activity in hemodynamically stable patients, the hemodynamic response to ketamine in unstable cardiovascular conditions is not clear. No studies to the best of our knowledge compared Ketamine-based and opioid-based protocols in rapid sequence induction of anesthesia in hemodynamically unstable patients.
In this study, patients with severe sepsis or septic shock scheduled for surgery will be assigned to receive either ketamine or fentanyl for induction of anesthesia. After induction of anesthesia, endotracheal tube will be inserted aided by succinyl choline. Invasive blood pressure will be monitored through a transducer connected to arterial catheter. Electrical velocimetry (cardiometry) device will be used for non-invasive monitoring of cardiac output and stroke volume.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will receive :1 mg/Kg ketamine for induction of anesthesia
Other names: Katalar
Patients will receive :2.5 mcg/Kg fentanyl for induction of anesthesia
Patients will receive 0.05 mg/Kg midazolam
Other names: Dormicum
Time frame: 30 minutes after induction of anesthesia
Mean arterial blood pressure measured by invasive transducer attached to arterial catheter
Time frame: 30 minutes after induction of anesthesia
cardiac output measured in litres per minute measured by electrical velocimetry
Time frame: 30 minutes after induction of anesthesia
cardiac stroke volume in milliliters measured by electrical velocimetry
Time frame: 30 minutes after induction of anesthesia
heart rate measured in beat per minute
Time frame: 30 minutes after induction of anesthesia
serum lactate measured in mmol/liter
Time frame: 30 minutes after induction of anesthesia
total dose of norepinephrine measured in micrograms
Time frame: 30 minutes
the concentration of inhalational anesthetic (%)
Time frame: 5 minutes
The percent of patients with severe hypotension after induction of anesthesia requiring stoppage of inhalational anesthesia or increasing the dose of vasopressors
Cairo University
Other
Ketamine-based Versus Opioid-based for Rapid-sequence Induction of Anesthesia in Patients With Septic Shock
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06363149
Blood Coagulation Disorders, Critical Illness
Lucknow, Uttar Pradesh, India
View Trial DetailsNCT07695337
Infections, Inflammation
Banhā, Qalyubia Governorate, Egypt
View Trial DetailsNCT05824767
Infections, Inflammation
Albuquerque, New Mexico, United States
View Trial DetailsNCT07313670
Infections, Inflammation
Karachi, Sindh, Pakistan
View Trial Details